Related Experiment Video
Updated: Mar 25, 2026

A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology
Published on: February 7, 2015
Coronary microvascular dysfunction in chronic inflammatory rheumatoid diseases
Alessia Faccini1, Juan Carlos Kaski2, Paolo G Camici3
1Vita-Salute University and San Raffaele Scientific Institute, Via Olgettina 58, 20132 Milan, Italy.
Insights
Chronic inflammatory rheumatoid diseases (CIRD) increase cardiovascular risk. Understanding coronary microvascular dysfunction (CMD) in CIRD is key to developing targeted therapies and preventing heart disease.
Area of Science:
- Cardiology
- Rheumatology
- Immunology
Background:
- Chronic inflammatory rheumatoid diseases (CIRD) like rheumatoid arthritis, lupus, and scleroderma are significant risk factors for ischemic heart disease.
- CIRD contributes to high cardiovascular morbidity and mortality.
- Inflammation in CIRD can impair coronary microvascular function, leading to myocardial ischemia and cardiovascular events, even without obstructive coronary artery disease.
Purpose of the Study:
- To review the pathogenic mechanisms underlying coronary microvascular dysfunction (CMD) in CIRD.
- To discuss controversial therapeutic strategies for CMD in CIRD.
- To propose a diagnostic algorithm for CMD in CIRD patients to guide preventive measures.
Main Methods:
- Literature review of pathogenic mechanisms.
- Analysis of therapeutic strategies and their outcomes.
- Development of a proposed diagnostic algorithm.
Main Results:
- Inflammation in CIRD directly impacts coronary microvascular function.
- Current therapeutic strategies show controversial results.
- A diagnostic algorithm can aid in identifying CMD.
Conclusions:
- Understanding CMD mechanisms in CIRD is crucial for identifying therapeutic targets.
- Early identification of CMD through a diagnostic algorithm may prevent angina and slow disease progression.
- Targeting CMD could reduce cardiovascular events in CIRD patients.
Abstract:
Chronic inflammatory rheumatoid diseases (CIRD) such as rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis are an important risk factor for the development of ischaemic heart disease and a source of high cardiovascular morbidity and mortality. In patients affected by CIRD, inflammation can affect coronary microvascular function and contribute to the development of myocardial ischemia and cardiovascular events, even in the absence of obstructive epicardial coronary artery disease. Understanding the molecular aspects that underlie the development of coronary microvascular dysfunction (CMD) in CIRD is of fundamental importance to identify specific therapeutic targets. In this article, we review the pathogenic mechanisms leading to CMD in CIRD, including the controversial results obtained with the use of different therapeutic strategies. We also propose that a practical diagnostic algorithm as the identification of CMD in patients with CIRD may lead to effective measures to prevent the development of angina pectoris and reduce the risk of rapid disease progression.
More Related Videos
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Myocarditis I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Coronary Artery Disease I: Introduction
Coronary Artery Disease III: Clinical Manifestations

